Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | CTSA | P10619 | 8/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GLS | O94925 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7042230 | 0.90 | CYP3A4 (0.34) | PKMKEAP1NFE2L2L3MBTL1ALDH1A1 | |
| SCHEMBL7044012 | 0.82 | ALDH1A1 (0.38) | PKML3MBTL1ALDH1A1POLBNPSR1 | |
| SCHEMBL7041596 | 0.80 | KEAP1 (0.40) | PKMKEAP1NFE2L2L3MBTL1ALDH1A1 | |
| SCHEMBL7042380 | 0.75 | SLC6A2 (0.42) | PKML3MBTL1ALDH1A1NPSR1 | |
| SCHEMBL7040594 | 0.73 | PPARG (0.39) | TSHR | |
| SCHEMBL7044014 | 0.72 | ALDH1A1 (0.38) | L3MBTL1ALDH1A1NPSR1 | |
| SCHEMBL7086483 | 0.72 | THRB (0.37) | ALDH1A1TSHR | |
| SCHEMBL7041600 | 0.71 | CYP3A4 (0.42) | PKMKEAP1NFE2L2L3MBTL1ALDH1A1 | |
| SCHEMBL7039621 | 0.71 | ALDH1A1 (0.41) | ALDH1A1POLBCA2TSHR | |
| SCHEMBL7038722 | 0.67 | LMNA (0.40) | ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | PKM 4816/4885KEAP1 1276/4885NFE2L2 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.